Carolyn Elizabeth Mountford, D.Phil.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Spectroscopy | 83 | 2019 | 3781 | 5.300 |
Why?
|
| Fucose | 7 | 2019 | 122 | 1.980 |
Why?
|
| Choline | 10 | 2022 | 518 | 0.960 |
Why?
|
| Genes, BRCA2 | 2 | 2015 | 592 | 0.790 |
Why?
|
| Breast | 5 | 2015 | 1975 | 0.780 |
Why?
|
| Genes, BRCA1 | 2 | 2015 | 755 | 0.760 |
Why?
|
| Breast Neoplasms | 18 | 2022 | 21162 | 0.740 |
Why?
|
| Lipid Metabolism | 7 | 2015 | 1901 | 0.730 |
Why?
|
| Prostatic Diseases | 2 | 2008 | 57 | 0.610 |
Why?
|
| Diagnosis, Computer-Assisted | 3 | 2012 | 710 | 0.610 |
Why?
|
| Prostate | 4 | 2008 | 1781 | 0.580 |
Why?
|
| Lipids | 14 | 2022 | 3344 | 0.520 |
Why?
|
| Protons | 14 | 2019 | 1112 | 0.500 |
Why?
|
| Brain | 10 | 2019 | 27454 | 0.480 |
Why?
|
| Membrane Lipids | 11 | 1996 | 251 | 0.460 |
Why?
|
| Carbohydrates | 2 | 2014 | 389 | 0.440 |
Why?
|
| Polysaccharides | 1 | 2019 | 1024 | 0.420 |
Why?
|
| Biopsy, Needle | 7 | 2001 | 1627 | 0.390 |
Why?
|
| Creatine | 3 | 2018 | 427 | 0.360 |
Why?
|
| Brain Chemistry | 2 | 2011 | 962 | 0.350 |
Why?
|
| Biopsy | 9 | 2009 | 6808 | 0.350 |
Why?
|
| Magnetic Resonance Imaging | 18 | 2019 | 36849 | 0.330 |
Why?
|
| Adenocarcinoma, Follicular | 3 | 1996 | 326 | 0.280 |
Why?
|
| Thyroid Neoplasms | 7 | 2006 | 2360 | 0.280 |
Why?
|
| Muscles | 2 | 2011 | 1582 | 0.270 |
Why?
|
| Sensitivity and Specificity | 16 | 2012 | 14737 | 0.270 |
Why?
|
| Cell Membrane | 12 | 1992 | 3663 | 0.270 |
Why?
|
| Vinblastine | 4 | 1989 | 488 | 0.260 |
Why?
|
| Muscle, Skeletal | 2 | 2011 | 4981 | 0.250 |
Why?
|
| Algorithms | 7 | 2012 | 14154 | 0.250 |
Why?
|
| Image Enhancement | 5 | 2010 | 2894 | 0.250 |
Why?
|
| Breast Diseases | 1 | 2008 | 443 | 0.240 |
Why?
|
| Mammary Neoplasms, Experimental | 9 | 1994 | 506 | 0.240 |
Why?
|
| Neoplasm, Residual | 1 | 2010 | 1019 | 0.230 |
Why?
|
| Glutamine | 2 | 2022 | 578 | 0.230 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2019 | 4641 | 0.220 |
Why?
|
| Mutation | 3 | 2022 | 30228 | 0.210 |
Why?
|
| Biopsy, Fine-Needle | 3 | 2009 | 1132 | 0.210 |
Why?
|
| Methylmalonic Acid | 1 | 2022 | 50 | 0.210 |
Why?
|
| Triglycerides | 11 | 1996 | 2465 | 0.210 |
Why?
|
| Proteolipids | 3 | 1987 | 112 | 0.200 |
Why?
|
| Spinal Cord Injuries | 1 | 2010 | 929 | 0.200 |
Why?
|
| Sterols | 1 | 2022 | 64 | 0.200 |
Why?
|
| Lymphatic Metastasis | 7 | 2009 | 2925 | 0.200 |
Why?
|
| Taurine | 1 | 2022 | 92 | 0.190 |
Why?
|
| Phosphorylcholine | 1 | 2022 | 153 | 0.190 |
Why?
|
| Contrast Media | 3 | 2011 | 5336 | 0.190 |
Why?
|
| Adenocarcinoma | 12 | 2006 | 6406 | 0.190 |
Why?
|
| Lymph Nodes | 4 | 2005 | 3471 | 0.190 |
Why?
|
| Humans | 87 | 2022 | 768393 | 0.190 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2010 | 2820 | 0.180 |
Why?
|
| Glutamates | 1 | 2022 | 385 | 0.180 |
Why?
|
| Neoplasm Metastasis | 9 | 2009 | 4921 | 0.180 |
Why?
|
| Female | 48 | 2022 | 397089 | 0.170 |
Why?
|
| Uterine Cervical Neoplasms | 5 | 2006 | 2044 | 0.170 |
Why?
|
| Cholesterol Esters | 4 | 1996 | 72 | 0.170 |
Why?
|
| Receptors, Progesterone | 1 | 2004 | 1145 | 0.170 |
Why?
|
| Artifacts | 2 | 2011 | 1930 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 10 | 2001 | 6132 | 0.160 |
Why?
|
| Barrett Esophagus | 1 | 2003 | 494 | 0.160 |
Why?
|
| Precancerous Conditions | 3 | 2002 | 984 | 0.150 |
Why?
|
| Cryptococcus neoformans | 3 | 2005 | 121 | 0.150 |
Why?
|
| Middle Aged | 24 | 2022 | 223491 | 0.150 |
Why?
|
| Specimen Handling | 1 | 2003 | 708 | 0.150 |
Why?
|
| Prostatic Neoplasms | 3 | 2008 | 11221 | 0.150 |
Why?
|
| Neoplasms | 11 | 2006 | 22385 | 0.150 |
Why?
|
| Cryopreservation | 1 | 2003 | 733 | 0.150 |
Why?
|
| Neuraminidase | 3 | 1982 | 195 | 0.140 |
Why?
|
| Low Back Pain | 1 | 2006 | 989 | 0.140 |
Why?
|
| Ovarian Neoplasms | 4 | 2008 | 4907 | 0.140 |
Why?
|
| Leukemia, Lymphoid | 4 | 1986 | 311 | 0.140 |
Why?
|
| Adenoma | 4 | 1996 | 2163 | 0.140 |
Why?
|
| Neoplasm Invasiveness | 6 | 2001 | 3633 | 0.140 |
Why?
|
| Phospholipids | 6 | 1994 | 783 | 0.140 |
Why?
|
| Glioblastoma | 3 | 2011 | 3526 | 0.140 |
Why?
|
| Adult | 24 | 2019 | 223640 | 0.140 |
Why?
|
| Reproducibility of Results | 10 | 2012 | 20224 | 0.140 |
Why?
|
| Onium Compounds | 1 | 1996 | 27 | 0.140 |
Why?
|
| Lipoproteins | 4 | 1991 | 880 | 0.130 |
Why?
|
| Spectrum Analysis | 3 | 2015 | 449 | 0.130 |
Why?
|
| Receptors, Estrogen | 1 | 2004 | 2247 | 0.130 |
Why?
|
| Amino Acids | 5 | 2008 | 1716 | 0.120 |
Why?
|
| Influenza A virus | 4 | 1982 | 460 | 0.120 |
Why?
|
| Rats, Inbred F344 | 7 | 2003 | 826 | 0.120 |
Why?
|
| Chemotaxis | 2 | 1996 | 600 | 0.120 |
Why?
|
| Organophosphorus Compounds | 1 | 1996 | 207 | 0.120 |
Why?
|
| Gyrus Cinguli | 3 | 2018 | 1137 | 0.120 |
Why?
|
| Pain | 1 | 2010 | 5103 | 0.120 |
Why?
|
| Colorectal Neoplasms | 6 | 1996 | 6971 | 0.120 |
Why?
|
| Mammography | 3 | 2022 | 2434 | 0.120 |
Why?
|
| Menopause | 1 | 2022 | 1653 | 0.120 |
Why?
|
| Rats | 19 | 2005 | 23835 | 0.110 |
Why?
|
| Hydrogen | 2 | 1996 | 171 | 0.110 |
Why?
|
| Brain Neoplasms | 3 | 2011 | 9198 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2011 | 9063 | 0.110 |
Why?
|
| CHO Cells | 2 | 1993 | 1380 | 0.110 |
Why?
|
| Sarcoma, Experimental | 1 | 1993 | 117 | 0.110 |
Why?
|
| Citrates | 2 | 2003 | 134 | 0.110 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 1996 | 2846 | 0.100 |
Why?
|
| Adenoma, Oxyphilic | 1 | 1994 | 152 | 0.100 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2010 | 1496 | 0.100 |
Why?
|
| Prostatic Hyperplasia | 2 | 2008 | 523 | 0.100 |
Why?
|
| Thalamus | 2 | 2010 | 1050 | 0.100 |
Why?
|
| Diagnosis, Differential | 10 | 2009 | 13020 | 0.100 |
Why?
|
| Suppuration | 1 | 1991 | 61 | 0.090 |
Why?
|
| Cryptococcosis | 2 | 2003 | 103 | 0.090 |
Why?
|
| Male | 24 | 2019 | 364902 | 0.090 |
Why?
|
| Rectum | 1 | 1996 | 902 | 0.090 |
Why?
|
| Spectrophotometry | 1 | 2011 | 292 | 0.090 |
Why?
|
| Melanoma | 3 | 2005 | 5705 | 0.090 |
Why?
|
| Lymphocytes | 2 | 1994 | 2611 | 0.090 |
Why?
|
| False Positive Reactions | 2 | 2010 | 962 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2019 | 22296 | 0.090 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 1994 | 391 | 0.090 |
Why?
|
| Laminin | 1 | 1992 | 406 | 0.090 |
Why?
|
| Cervix Uteri | 2 | 1994 | 577 | 0.090 |
Why?
|
| Glucose | 1 | 2022 | 4352 | 0.090 |
Why?
|
| Cell Line, Transformed | 3 | 1996 | 867 | 0.090 |
Why?
|
| Radio Waves | 1 | 2011 | 254 | 0.080 |
Why?
|
| Endopeptidases | 1 | 1993 | 765 | 0.080 |
Why?
|
| Carcinoma in Situ | 4 | 2009 | 789 | 0.080 |
Why?
|
| Central Nervous System Diseases | 1 | 2014 | 523 | 0.080 |
Why?
|
| Cholesterol | 6 | 1996 | 2912 | 0.080 |
Why?
|
| Nucleotidases | 1 | 1988 | 29 | 0.080 |
Why?
|
| Body Water | 1 | 2010 | 340 | 0.080 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2005 | 508 | 0.080 |
Why?
|
| Carcinoma, Papillary | 1 | 1994 | 793 | 0.080 |
Why?
|
| Cell Line | 13 | 1992 | 15597 | 0.080 |
Why?
|
| Apolipoproteins A | 1 | 1989 | 96 | 0.080 |
Why?
|
| Brain Diseases | 2 | 2010 | 1552 | 0.080 |
Why?
|
| alpha-L-Fucosidase | 1 | 1988 | 8 | 0.080 |
Why?
|
| Proteoglycans | 1 | 1992 | 807 | 0.080 |
Why?
|
| Transducers | 1 | 2010 | 245 | 0.080 |
Why?
|
| gamma-Glutamyltransferase | 1 | 1988 | 144 | 0.080 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2008 | 81 | 0.080 |
Why?
|
| Colon | 1 | 1996 | 1805 | 0.070 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1989 | 167 | 0.070 |
Why?
|
| Prefrontal Cortex | 2 | 2010 | 2257 | 0.070 |
Why?
|
| Lactates | 3 | 1996 | 401 | 0.070 |
Why?
|
| Aged | 16 | 2012 | 171562 | 0.070 |
Why?
|
| Skin Neoplasms | 2 | 2005 | 5857 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2019 | 8731 | 0.070 |
Why?
|
| Cystadenoma | 1 | 1987 | 77 | 0.070 |
Why?
|
| Lysine | 2 | 2003 | 988 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 1994 | 4069 | 0.070 |
Why?
|
| Cell Transformation, Viral | 3 | 1982 | 530 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2022 | 54920 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2009 | 3411 | 0.060 |
Why?
|
| Drug Resistance | 5 | 1993 | 1595 | 0.060 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1988 | 480 | 0.060 |
Why?
|
| Animals | 30 | 2010 | 169337 | 0.060 |
Why?
|
| ROC Curve | 2 | 2008 | 3623 | 0.060 |
Why?
|
| Candida | 2 | 2004 | 172 | 0.060 |
Why?
|
| Phantoms, Imaging | 2 | 2011 | 2528 | 0.060 |
Why?
|
| Alkaline Phosphatase | 1 | 1988 | 864 | 0.060 |
Why?
|
| Subtraction Technique | 1 | 2008 | 519 | 0.060 |
Why?
|
| Young Adult | 4 | 2019 | 60049 | 0.060 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2009 | 526 | 0.060 |
Why?
|
| Glutamic Acid | 1 | 2011 | 1193 | 0.060 |
Why?
|
| Meningitis, Cryptococcal | 1 | 2005 | 67 | 0.060 |
Why?
|
| Respiratory Mechanics | 1 | 2009 | 722 | 0.060 |
Why?
|
| Cricetinae | 4 | 1993 | 2423 | 0.060 |
Why?
|
| T-Lymphocytes | 5 | 1989 | 10267 | 0.060 |
Why?
|
| Brain Abscess | 1 | 2005 | 123 | 0.060 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1993 | 1167 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2010 | 2931 | 0.060 |
Why?
|
| Feasibility Studies | 3 | 2008 | 5313 | 0.060 |
Why?
|
| Thyroid Nodule | 3 | 1996 | 767 | 0.060 |
Why?
|
| Collagen | 1 | 1992 | 2646 | 0.050 |
Why?
|
| Antibody Specificity | 2 | 1982 | 1065 | 0.050 |
Why?
|
| Carcinoma | 4 | 1996 | 2341 | 0.050 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2003 | 118 | 0.050 |
Why?
|
| Complement Fixation Tests | 1 | 1982 | 68 | 0.050 |
Why?
|
| Pattern Recognition, Automated | 1 | 2009 | 998 | 0.050 |
Why?
|
| Fibroblasts | 5 | 1996 | 4177 | 0.050 |
Why?
|
| Lung Diseases, Fungal | 1 | 2003 | 124 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2019 | 41795 | 0.050 |
Why?
|
| Colonic Neoplasms | 3 | 1996 | 2544 | 0.050 |
Why?
|
| Lipoproteins, VLDL | 3 | 1989 | 201 | 0.050 |
Why?
|
| Neoplasm Staging | 3 | 2011 | 11254 | 0.050 |
Why?
|
| Movement | 1 | 2009 | 1490 | 0.050 |
Why?
|
| Central Nervous System Fungal Infections | 1 | 2001 | 24 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2010 | 3553 | 0.050 |
Why?
|
| Staphylococcus | 1 | 2001 | 146 | 0.050 |
Why?
|
| Streptococcus | 1 | 2001 | 198 | 0.050 |
Why?
|
| Aged, 80 and over | 7 | 2009 | 59686 | 0.050 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 1998 | 1094 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 2708 | 0.040 |
Why?
|
| Enterococcus | 1 | 2001 | 159 | 0.040 |
Why?
|
| Cell Fractionation | 2 | 1992 | 247 | 0.040 |
Why?
|
| Orthomyxoviridae | 1 | 1981 | 148 | 0.040 |
Why?
|
| Leukemia, Experimental | 1 | 1980 | 225 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 1986 | 1882 | 0.040 |
Why?
|
| Neoplasms, Experimental | 1 | 1984 | 1232 | 0.040 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1988 | 1558 | 0.040 |
Why?
|
| Thyroid Gland | 2 | 1996 | 1172 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2011 | 3579 | 0.040 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2001 | 342 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 1991 | 3610 | 0.040 |
Why?
|
| Fatty Acids | 3 | 1992 | 1815 | 0.040 |
Why?
|
| Neutrophils | 1 | 1991 | 3785 | 0.040 |
Why?
|
| Epithelium | 1 | 2003 | 1609 | 0.040 |
Why?
|
| Neoadjuvant Therapy | 1 | 2010 | 2909 | 0.040 |
Why?
|
| Phosphocreatine | 1 | 1998 | 261 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 1993 | 2017 | 0.040 |
Why?
|
| Time Factors | 2 | 2011 | 40272 | 0.040 |
Why?
|
| Creatinine | 1 | 2003 | 1915 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2005 | 1429 | 0.040 |
Why?
|
| Bacterial Infections | 1 | 2005 | 1397 | 0.030 |
Why?
|
| Prognosis | 3 | 2006 | 30022 | 0.030 |
Why?
|
| Esophagus | 1 | 2003 | 1042 | 0.030 |
Why?
|
| Equipment Failure Analysis | 2 | 2010 | 848 | 0.030 |
Why?
|
| Models, Biological | 2 | 1994 | 9493 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 1982 | 1082 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 3 | 1993 | 6234 | 0.030 |
Why?
|
| Simian virus 40 | 1 | 1996 | 292 | 0.030 |
Why?
|
| Diglycerides | 1 | 1996 | 176 | 0.030 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 1996 | 161 | 0.030 |
Why?
|
| Culture Media, Serum-Free | 1 | 1996 | 148 | 0.030 |
Why?
|
| Glycolipids | 2 | 1987 | 206 | 0.030 |
Why?
|
| Aspartic Acid | 1 | 2018 | 577 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2006 | 3581 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2009 | 4076 | 0.030 |
Why?
|
| Kinetics | 4 | 1986 | 6333 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2010 | 9379 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 1982 | 9261 | 0.030 |
Why?
|
| Hexoses | 1 | 1994 | 29 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 1996 | 699 | 0.030 |
Why?
|
| Lymphocyte Activation | 3 | 1994 | 5496 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2004 | 15455 | 0.030 |
Why?
|
| Risk Factors | 1 | 2022 | 74962 | 0.030 |
Why?
|
| DNA Replication | 1 | 1981 | 1428 | 0.030 |
Why?
|
| Intestinal Mucosa | 2 | 1996 | 3048 | 0.030 |
Why?
|
| Carcinoma, Medullary | 1 | 1994 | 116 | 0.030 |
Why?
|
| Rats, Inbred Strains | 2 | 2005 | 2087 | 0.030 |
Why?
|
| Antibodies | 1 | 1981 | 2425 | 0.030 |
Why?
|
| Culture Media | 2 | 2001 | 898 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 1996 | 13697 | 0.030 |
Why?
|
| Hyperplasia | 1 | 1996 | 1153 | 0.030 |
Why?
|
| Atrophy | 1 | 2018 | 1648 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 1986 | 2559 | 0.030 |
Why?
|
| Membrane Glycoproteins | 2 | 1994 | 3712 | 0.030 |
Why?
|
| Lipoproteins, HDL | 2 | 1989 | 682 | 0.030 |
Why?
|
| Sialic Acids | 1 | 1992 | 123 | 0.030 |
Why?
|
| Esophageal Neoplasms | 1 | 2003 | 1676 | 0.030 |
Why?
|
| Lung | 2 | 2009 | 10089 | 0.020 |
Why?
|
| Mice | 9 | 1996 | 82017 | 0.020 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 1992 | 175 | 0.020 |
Why?
|
| Ultracentrifugation | 1 | 1992 | 182 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2002 | 1959 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2018 | 1143 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 1996 | 1081 | 0.020 |
Why?
|
| Adolescent | 4 | 2010 | 89184 | 0.020 |
Why?
|
| Cell Count | 1 | 1996 | 1833 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 1992 | 440 | 0.020 |
Why?
|
| Equipment Design | 2 | 2010 | 3529 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1996 | 2488 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 1992 | 1086 | 0.020 |
Why?
|
| Thyroidectomy | 1 | 1996 | 914 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2002 | 2336 | 0.020 |
Why?
|
| Chick Embryo | 2 | 1982 | 975 | 0.020 |
Why?
|
| Consensus | 1 | 2019 | 3212 | 0.020 |
Why?
|
| Carcinoma, Ductal | 1 | 2009 | 97 | 0.020 |
Why?
|
| Reference Values | 2 | 2009 | 4941 | 0.020 |
Why?
|
| Sputum | 1 | 1991 | 512 | 0.020 |
Why?
|
| Forecasting | 1 | 1997 | 2948 | 0.020 |
Why?
|
| Fibroma | 1 | 2009 | 201 | 0.020 |
Why?
|
| 5'-Nucleotidase | 1 | 1988 | 164 | 0.020 |
Why?
|
| Lactic Acid | 1 | 1992 | 1140 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 1988 | 574 | 0.020 |
Why?
|
| Mice, Nude | 1 | 1993 | 3632 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 1993 | 1780 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2003 | 5831 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2011 | 2299 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2002 | 4365 | 0.020 |
Why?
|
| Particle Size | 1 | 1991 | 1653 | 0.020 |
Why?
|
| Genital Neoplasms, Female | 1 | 1992 | 539 | 0.020 |
Why?
|
| Freeze Fracturing | 1 | 1985 | 70 | 0.020 |
Why?
|
| Chylomicrons | 1 | 1985 | 26 | 0.020 |
Why?
|
| Electron Transport Complex IV | 1 | 1986 | 192 | 0.020 |
Why?
|
| Glioma | 1 | 2001 | 3526 | 0.020 |
Why?
|
| Thymus Gland | 2 | 1982 | 1266 | 0.020 |
Why?
|
| Lipid Bilayers | 1 | 1988 | 379 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 1994 | 1356 | 0.020 |
Why?
|
| History, 20th Century | 1 | 1994 | 2771 | 0.020 |
Why?
|
| Cardiolipins | 1 | 1985 | 83 | 0.020 |
Why?
|
| Ethers | 1 | 1985 | 73 | 0.020 |
Why?
|
| Edetic Acid | 1 | 1986 | 278 | 0.020 |
Why?
|
| Leukemia | 1 | 1994 | 1526 | 0.020 |
Why?
|
| Rats, Inbred WF | 1 | 2005 | 140 | 0.020 |
Why?
|
| Phosphatidylethanolamines | 1 | 1985 | 131 | 0.020 |
Why?
|
| Trypsin | 1 | 1986 | 491 | 0.020 |
Why?
|
| Hippocampus | 1 | 2018 | 3784 | 0.020 |
Why?
|
| Sphingomyelins | 1 | 1985 | 105 | 0.020 |
Why?
|
| Drug Combinations | 1 | 1992 | 2079 | 0.020 |
Why?
|
| Culture Techniques | 1 | 1985 | 530 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2005 | 222 | 0.020 |
Why?
|
| Random Allocation | 1 | 1989 | 2397 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1996 | 10776 | 0.010 |
Why?
|
| Chickens | 1 | 1986 | 845 | 0.010 |
Why?
|
| Diffusion | 1 | 1985 | 818 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2010 | 65379 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 1989 | 15649 | 0.010 |
Why?
|
| Hyperlipidemias | 1 | 1988 | 773 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2009 | 2363 | 0.010 |
Why?
|
| Pokeweed Mitogens | 1 | 1982 | 38 | 0.010 |
Why?
|
| Cell Survival | 1 | 1992 | 5792 | 0.010 |
Why?
|
| Propiolactone | 1 | 1982 | 6 | 0.010 |
Why?
|
| Lipoproteins, LDL | 1 | 1985 | 643 | 0.010 |
Why?
|
| Mitomycins | 1 | 1982 | 46 | 0.010 |
Why?
|
| Lipoprotein(a) | 1 | 1987 | 490 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1982 | 342 | 0.010 |
Why?
|
| Amantadine | 1 | 1982 | 59 | 0.010 |
Why?
|
| Serine | 1 | 1985 | 831 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1982 | 305 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 1991 | 1285 | 0.010 |
Why?
|
| Surface Properties | 1 | 1984 | 1167 | 0.010 |
Why?
|
| Hybridomas | 1 | 1982 | 444 | 0.010 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2005 | 740 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3794 | 0.010 |
Why?
|
| Candida albicans | 1 | 2004 | 375 | 0.010 |
Why?
|
| Genes, Viral | 1 | 1982 | 655 | 0.010 |
Why?
|
| Mice, Inbred AKR | 1 | 1980 | 104 | 0.010 |
Why?
|
| Disease Models, Animal | 3 | 2005 | 18362 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1993 | 4936 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 1981 | 513 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1981 | 2172 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 1989 | 2660 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1981 | 1753 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1982 | 1526 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2001 | 1890 | 0.010 |
Why?
|
| Binding Sites | 1 | 1985 | 6017 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1994 | 11668 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2010 | 6277 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2003 | 19022 | 0.010 |
Why?
|
| Ion Transport | 1 | 1995 | 322 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1995 | 685 | 0.010 |
Why?
|
| Virus Replication | 1 | 1981 | 2458 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 8634 | 0.010 |
Why?
|
| Mitochondria | 1 | 1986 | 3675 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2009 | 6670 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1987 | 12805 | 0.010 |
Why?
|
| Phenotype | 1 | 2009 | 16721 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1982 | 4785 | 0.000 |
Why?
|
| Multivariate Analysis | 1 | 2001 | 12092 | 0.000 |
Why?
|
| Blood Chemical Analysis | 1 | 1988 | 436 | 0.000 |
Why?
|
| Child | 1 | 1994 | 80891 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 1995 | 9562 | 0.000 |
Why?
|
| Myocardium | 1 | 1995 | 4788 | 0.000 |
Why?
|
| Liver | 1 | 1995 | 7574 | 0.000 |
Why?
|
| Adipose Tissue | 1 | 1988 | 3334 | 0.000 |
Why?
|